Publication | Closed Access
The use of BRL26921 (APSAC) as fibrinolytic therapy in acute myocardial infarction
20
Citations
0
References
1985
Year
ThrombosisPercutaneous Coronary InterventionCardiorenal SyndromesCardiovascular DiseaseJournal ArticleFibrinolysisCardiologyFibrinolytic TherapyPharmacotherapyGlasgow G21 3UwPlatelet AntagonistMedicineAnticoagulantAtherosclerosisAcute Myocardial InfarctionMyocardial Infarction
Journal Article The use of BRL26921 (APSAC) as fibrinolytic therapy in acute myocardial infarction Get access W. S. HILLIS, W. S. HILLIS Department of Materia Medica, University of Glasgow, Stobhill General HospitalBalornock Road, Glasgow G21 3UW, U.K. Search for other works by this author on: Oxford Academic PubMed Google Scholar R. S. HORNUNG R. S. HORNUNG Department of Materia Medica, University of Glasgow, Stobhill General HospitalBalornock Road, Glasgow G21 3UW, U.K. Search for other works by this author on: Oxford Academic PubMed Google Scholar European Heart Journal, Volume 6, Issue 11, November 1985, Pages 909–912, https://doi.org/10.1093/oxfordjournals.eurheartj.a061787 Published: 01 November 1985